ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer

BACKGROUND: Approximately half of the prostate carcinomas are characterized by a chromosomal rearrangement fusing the androgen-regulated gene TMPRSS2 to the oncogenic ETS transcription factor ERG. Aim of this study was to comprehensively analyze the role and impact of the ERG rearrangement and prote...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gsponer, JR, Braun, M, Scheble, VJ, Zellweger, T, Bachmann, A, Perner, S, Vlajnic, T, Srivastava, M, Tan, S-H, Dobi, A, Sesterhenn, IA, Srivastava, S, Bubendorf, L, Ruiz, C
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4097053/
https://ncbi.nlm.nih.gov/pubmed/24469092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2013.62
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak